• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Recent Advances in the Study of 4-Methoxy-3-methyl-4'-(trifluoromethoxy)biphenyl (CAS: 1261661-86-2)

The compound 4-Methoxy-3-methyl-4'-(trifluoromethoxy)biphenyl (CAS: 1261661-86-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This biphenyl derivative, characterized by its methoxy and trifluoromethoxy substituents, has shown promising potential in various therapeutic applications, including anti-inflammatory and anticancer activities. Recent studies have focused on elucidating its molecular mechanisms, pharmacokinetic properties, and synthetic pathways to optimize its efficacy and safety profile.

A study published in the Journal of Medicinal Chemistry (2023) investigated the compound's role as a modulator of the NF-κB signaling pathway, which is implicated in chronic inflammation and cancer progression. The researchers synthesized a series of derivatives, including 4-Methoxy-3-methyl-4'-(trifluoromethoxy)biphenyl, and evaluated their inhibitory effects on NF-κB activation. The results demonstrated that this compound exhibited potent anti-inflammatory activity in vitro and in vivo, with minimal cytotoxicity, suggesting its potential as a lead compound for developing novel anti-inflammatory drugs.

In another study, researchers explored the compound's application in oncology. Preclinical trials revealed that 4-Methoxy-3-methyl-4'-(trifluoromethoxy)biphenyl could induce apoptosis in certain cancer cell lines by targeting the PI3K/Akt/mTOR pathway. The study highlighted the compound's ability to selectively inhibit cancer cell proliferation while sparing normal cells, a critical advantage for reducing side effects in potential therapeutic applications. Further pharmacokinetic studies indicated favorable bioavailability and metabolic stability, supporting its candidacy for further drug development.

The synthetic chemistry of 4-Methoxy-3-methyl-4'-(trifluoromethoxy)biphenyl has also been a focus of recent research. A novel and scalable synthesis route was reported in Organic Process Research & Development (2024), which improved yield and purity while reducing production costs. This advancement is expected to facilitate large-scale production for clinical trials and commercial applications. The study also provided insights into the compound's stability under various conditions, which is crucial for formulation development.

Despite these promising findings, challenges remain in translating 4-Methoxy-3-methyl-4'-(trifluoromethoxy)biphenyl into clinical use. Issues such as optimal dosing, long-term safety, and potential drug-drug interactions need to be addressed through rigorous preclinical and clinical studies. However, the compound's unique chemical structure and biological activities position it as a valuable candidate for further investigation in the pharmaceutical industry.

In conclusion, recent research on 4-Methoxy-3-methyl-4'-(trifluoromethoxy)biphenyl (CAS: 1261661-86-2) underscores its potential as a versatile therapeutic agent. Its dual anti-inflammatory and anticancer properties, coupled with advancements in synthetic chemistry, make it a compelling subject for future studies. Continued exploration of its mechanisms and applications will likely yield significant contributions to the field of chemical biology and drug discovery.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)